Notice: This company has been marked as potentially delisted and may not be actively trading. Interpace Biosciences (IDXG) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsEarningsHeadlinesTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period PDI: Beware The Massive NAV PremiumNovember 13 at 5:02 AM | seekingalpha.comInterpace Biosciences Inc.November 9, 2024 | wsj.comInterpace Biosciences Reports Impressive Q3 2024 GrowthNovember 7, 2024 | markets.businessinsider.comInterpace Biosciences Announces Record Third Quarter 2024 Financial and Business ResultsNovember 4, 2024 | globenewswire.comPDI: The Big ROC Bath, 13.5% 'Yield'October 27, 2024 | seekingalpha.comInterpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to NasdaqOctober 15, 2024 | globenewswire.comHealthcare Stocks Pre-Market MoversOctober 13, 2024 | benzinga.comPF42.SG,0P00019E71,0 (PF42.SG)August 21, 2024 | finance.yahoo.comInterpace Biosciences Announces Record Second Quarter 2024 Financial and Business ResultsAugust 1, 2024 | globenewswire.comInterpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic CystsJuly 29, 2024 | globenewswire.comPDI: PIMCO Vs. BlackRock, 10 Big-Yield CEFs ComparedJuly 21, 2024 | seekingalpha.comPDI: Get In Before The Fed Pivots And Lock In A 14% YieldJuly 13, 2024 | seekingalpha.comPDI: I Sold A Chunk Of The Position But I Am Still Bullish On This Fund Going ForwardJuly 2, 2024 | seekingalpha.comInterpace Biosciences Announces First Quarter 2024 Financial and Business ResultsMay 9, 2024 | globenewswire.comPDI Under $20 Exceeds A 13% Yield With Potential Upside On The HorizonApril 3, 2024 | seekingalpha.comInterpace Biosciences announces preliminary Q4 revenue of $10.3MMarch 7, 2024 | msn.comInterpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business ResultsMarch 7, 2024 | globenewswire.comPDI: What Lurks Under The Hood Of PIMCO's Crown JewelMarch 1, 2024 | seekingalpha.comInterpace Biosciences Stock (OTC:IDXG) Dividends: History, Yield and DatesFebruary 22, 2024 | benzinga.comPDI: 14% Yield, But Risks Are Rising (Rating Downgrade)January 24, 2024 | seekingalpha.comPDI Looks Like It Bottomed And Is Still Yielding Over 14%January 9, 2024 | seekingalpha.comPDI: Lag Likely To ContinueDecember 5, 2023 | seekingalpha.comInterpace Biosciences Announces Record Third Quarter 2023 Financial and Business ResultsNovember 8, 2023 | finance.yahoo.comPDI: Pain Could Be On The HorizonOctober 24, 2023 | seekingalpha.comPDI: Pricing Improves, Fundamentals Stay Poor, We UpgradeOctober 1, 2023 | seekingalpha.comPDI: 100 Big Yield CEFs, REITs, MLPs - These 3 Worth ConsideringAugust 31, 2023 | seekingalpha.comInterpace Biosciences, Inc.: Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business ResultsAugust 10, 2023 | finanznachrichten.deInterpace Biosciences Announces Record Second Quarter 2023 Financial and Business ResultsAugust 9, 2023 | finance.yahoo.comInterpace Biosciences Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® ReimbursementJuly 10, 2023 | finance.yahoo.comInterpace Expects to Stop Offering PancraGEN® Test Due to CMS Decision to End Reimbursement as of July 17, 2023June 5, 2023 | finance.yahoo.comInterpace Biosciences, Inc.: Interpace Biosciences Announces Record First Quarter 2023 Financial and Business ResultsMay 13, 2023 | finanznachrichten.deInterpace Biosciences Announces Record First Quarter 2023 Financial and Business ResultsMay 12, 2023 | finance.yahoo.comInterpace Biosciences, Inc.: Interpace Biosciences Announces Full Year and Fourth Quarter 2022 Financial and Business ResultsMarch 28, 2023 | finanznachrichten.deInterpace Biosciences Announces Full Year and Fourth Quarter 2022 Financial and Business ResultsMarch 27, 2023 | finance.yahoo.comPDI And PTY: Unwelcome ROC, Buyer BewareMarch 13, 2023 | seekingalpha.comPriestly Demolition Inc. Promotes Leaders in a Restructuring Plan Designed to Support the Expansion of the Company Across North AmericaMarch 9, 2023 | financialpost.comWestport Signs Third Global Heavy-Duty OEM Collaboration Agreement to Demonstrate H2 HPDI™ Fuel System on IC Engine PlatformMarch 6, 2023 | financialpost.comPTY And PDI: Abysmal SetupsFebruary 20, 2023 | seekingalpha.comSeascape Capital Management Buys 3, Sells 2 in 4th QuarterJanuary 31, 2023 | gurufocus.comPDI Vs. PDO: Which High-Yielder Is Better?January 18, 2023 | seekingalpha.comPDI: More Patience RequiredDecember 7, 2022 | seekingalpha.comPDI: Utility Maximizing Income FundDecember 1, 2022 | seekingalpha.comInterpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going ConcernNovember 15, 2022 | finance.yahoo.comOrganon (OGN) Q3 Earnings and Revenues Top EstimatesNovember 3, 2022 | msn.comInterpace Biosciences Announces New Real-world Data; Presented at the American Thyroid Association 2022 Annual MeetingOctober 20, 2022 | finance.yahoo.comThe PDI And PTY DilemmaOctober 7, 2022 | seekingalpha.comInterpace Biosciences, Inc. (IDXG)October 4, 2022 | finance.yahoo.comPDI: Likely More Short-Term Pain AheadSeptember 20, 2022 | seekingalpha.comWestport Unveils H2 HPDI™ Fuel System for Sustainable Hydrogen Internal Combustion Mobility at IAASeptember 16, 2022 | financialpost.comColorado-based biotech acquires Morrisville labSeptember 9, 2022 | bizjournals.com Get Interpace Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Ever heard of this 8-day bitcoin profit window? (Ad)Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window. It’s coming up quick. IDXG Media Mentions By Week IDXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDXG News Sentiment▼0.000.54▲Average Medical News Sentiment IDXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDXG Articles This Week▼30▲IDXG Articles Average Week Get Interpace Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NeoGenomics News Today Veracyte News Today Laboratory Co. of America News Today Quest Diagnostics News Today DaVita News Today Chemed News Today R1 RCM News Today CorVel News Today Amedisys News Today AMN Healthcare Services News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDXG) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredIs Your 401(k) Safe? The Real Risk No One Sees ComingEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopp...Golden Crest | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Interpace Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Interpace Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
